# Progress Note 03 — Focused Visit (Follow-up)

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Mary Seacole (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-NI027-SYN-TD
- Date: 1877-04-13
- Fictional facility: St. Posthumous Health Center
- Fictional author: Adwoa Fairweather-Kent, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

- Visit type: Focused Visit (Follow-up)

## Chief complaint

Four-week review on two blood pressure medicines. **S**

## History of present illness

Mary Seacole returns four weeks after starting amlodipine and chlorthalidone. Her headaches stopped in the second week. Her home readings average 134/80. She has had no dizziness on standing and no ankle swelling. She began physical therapy three weeks ago, does her exercises most days and uses the cane the therapist fitted, in her right hand. The occupational therapist visited and a rail is being fitted on the stairs to her rooms. She has met the social prescribing link worker, who found a tai chi class near her home. Her knees hurt less. She wants to talk about the cholesterol tablet. **S**

| Element | Detail |
|---|---|
| Home readings | Average 134/80 mmHg |
| Headaches | Gone since the second week |
| Side effects | No dizziness or ankle swelling |
| Knees and falls | Physical therapy and a cane; no falls |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Neurological | Negative | No headaches, weakness or numbness |
| Cardiovascular | Negative | No dizziness on standing, palpitations or swelling |
| Musculoskeletal | Positive | Knee pain 5 out of 10, better with exercise |
| Genitourinary | Negative | Passing urine a little more in the mornings |

4 systems reviewed. **S**

## Current medications

- Diclofenac sodium 1% topical gel, 4 g rubbed into each painful knee up to four times a day **S**
- Amlodipine 5 mg oral tablet, one tablet daily **S**
- Chlorthalidone 12.5 mg oral tablet, one tablet each morning **S**
- Atorvastatin 20 mg oral tablet, one tablet daily **S**

## Allergies

- No known allergy **S**

## Objective

BP 138/82 mmHg; pulse 76 bpm; respirations 16/min; temperature 36.6 °C; oxygen saturation 97% on room air; weight 77.6 kg; BMI 31.5 kg/m². All vital signs are synthetic.

Sodium: 136 mmol/L; Potassium: 3.7 mmol/L; Creatinine: 0.95 mg/dL; eGFR (CKD-EPI 1872): 64 mL/min/1.73 m²; Glucose: 94 mg/dL; LVEF by echocardiogram: 64%; Knee pain (0 to 10): 5; KOOS JR (0 worst to 100 best): 56.6. All results are synthetic.

## Change since baseline

- Sodium: 140 mmol/L at baseline, 136 mmol/L at this visit **S**
- Potassium: 4.1 mmol/L at baseline, 3.7 mmol/L at this visit **S**
- Creatinine: 0.92 mg/dL at baseline, 0.95 mg/dL at this visit **S**
- eGFR (CKD-EPI 1872): 67 mL/min/1.73 m² at baseline, 64 mL/min/1.73 m² at this visit **S**
- Glucose: 96 mg/dL at baseline, 94 mg/dL at this visit **S**
- Knee pain (0 to 10): 6 at baseline, 5 at this visit **S**
- KOOS JR (0 worst to 100 best): 52.5 at baseline, 56.6 at this visit **S**

## Physical examination

| System | Finding |
|---|---|
| General | Well; blood pressure 138/82 seated, 134/80 standing at three minutes, pulse 76; weight 77.6 kg |
| Cardiovascular | Regular rhythm; no murmur; no edema |
| Musculoskeletal | No knee effusion; Timed Up and Go 14 seconds with the cane |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Stage 2 hypertension** (I10). Much improved: 138/82 in the clinic and 134/80 at home, not yet below 130/80. Sodium 136 and potassium 3.7 mmol/L, at the low end of normal on chlorthalidone; creatinine 0.95 mg/dL. Echocardiogram: ejection fraction 64% with mild concentric left ventricular hypertrophy, no heart failure. With a 10-year risk of about 14% and LDL 146 mg/dL, a moderate-intensity statin lowers her risk of stroke and heart attack; she chose to start it. **S**
   - Continue amlodipine 5 mg and chlorthalidone 12.5 mg; reassess at three months.
   - Atorvastatin 20 mg daily; lipid panel in four to twelve weeks.
   - Remember the sick-day rule for chlorthalidone.
2. **Knee osteoarthritis** (M17.0). Pain 5 out of 10; KOOS JR 56.6, up from 52.5. **S**
   - Continue exercise therapy; start tai chi when the physical therapy course ends.

## Protocol monitoring

Items the monitoring protocol calls for at this visit. **S**

| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Examination | Blood pressure in the clinic (seated, large cuff, two readings) and at home; target below 130/80 mmHg | Every visit | Completed today | 138/82 mmHg; home average 134/80 |
| Examination | Orthostatic blood pressure (lying and standing) | Every visit | Completed today | No orthostatic drop |
| Examination | Weight and BMI (5% weight-loss goal for knee osteoarthritis) | Every visit | Completed today | 77.6 kg, BMI 31.5 |
| Examination | Cardiac auscultation and edema | Every visit | Completed today | No murmur; no edema |
| Laboratory | Sodium, potassium, creatinine and eGFR | Two to four weeks after starting or changing a diuretic or ARB; then every six months on these medicines | Completed today | Four weeks after chlorthalidone: sodium 136, potassium 3.7, creatinine 0.95 mg/dL (eGFR 64), glucose 94 |
| Imaging | Echocardiogram | At diagnosis if stage 2 or left ventricular hypertrophy | Completed today | Ejection fraction 64%; mild concentric left ventricular hypertrophy; grade 1 diastolic dysfunction |
| Laboratory | Lipid panel | Four to twelve weeks after starting a statin, then yearly | Ordered | Atorvastatin 20 mg started today; panel in four to twelve weeks |
| Survey | Knee pain score (0 to 10) | Every visit | Completed today | 5 out of 10 |
| Survey | Knee function (KOOS JR) | Every visit | Completed today | KOOS JR 56.6 |
| Examination | Knee examination (range of motion, effusion, alignment, crepitus) | Every visit | Completed today | No effusion |
| Self-management | Exercise therapy, tai chi and self-management | Ongoing | Completed today | Physical therapy for three weeks; home exercises most days; cane in the right hand |
| Medication safety | NSAID safety (topical diclofenac; no oral NSAIDs) | Every visit | Completed today | Diclofenac gel only |
| Examination | STEADI assessment: Timed Up and Go, 30-second chair stand, 4-stage balance | At diagnosis of fall risk, then yearly or with a fall | Completed today | Timed Up and Go 14 seconds |
| Medication safety | Medicine review for fall risk and interactions (Beers criteria) | Every visit | Completed today | Chlorthalidone sodium check done; atorvastatin added |
| Self-management | Home safety, footwear, vision and assistive device | At diagnosis of fall risk, then yearly | Completed today | Occupational therapy visit done; stair rail being fitted; bath board supplied |
| Self-management | Her own remedies: interactions and how she uses them | Every visit | Completed today | Liquorice still paused; liniment on one knee and gel on the other |
| Self-management | Loneliness, costs and transport | Every visit | Completed today | Link worker found a tai chi class; generic medicines in 90-day supplies |

## Goal progress

- Blood pressure below 130/80 mmHg at home and in the clinic, without dizziness on standing. In progress; target 1877-09-14. **S**
- Headaches gone. Outcome by 1877-04-13: No headaches since the second week of treatment. **S**
- Knee pain 3 or less out of 10 and walking 20 minutes a day with a cane. In progress; target 1877-09-14. **S**
- Lose 5% of body weight (about 4 kg). In progress; target 1877-09-14. **S**
- No falls. In progress; target 1877-09-14. **S**

## Medication changes

- Started: Atorvastatin 20 mg oral tablet, one tablet daily **S**

## Guideline basis

- 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults (2025), American Heart Association and American College of Cardiology (Circulation 2025;152(11):e114-e218)
- 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee (2019), American College of Rheumatology and Arthritis Foundation (Arthritis Rheumatol 2020;72(2):220-233)
- STEADI: Stopping Elderly Accidents, Deaths, and Injuries (2026), Centers for Disease Control and Prevention
- Falls Prevention in Community-Dwelling Older Adults: Interventions (2024), U.S. Preventive Services Task Force
- 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol (2018), American Heart Association and American College of Cardiology (Circulation 2019;139(25):e1082-e1143)
- American Geriatrics Society 2023 Updated AGS Beers Criteria for Potentially Inappropriate Medication Use in Older Adults (2023), American Geriatrics Society (J Am Geriatr Soc 2023;71(7):2052-2081)
- Licorice Root (2026), National Center for Complementary and Integrative Health
- Ginger (2026), National Center for Complementary and Integrative Health
- CMID: Clinical Monitoring Intelligence Database, hypertension, osteoarthritis and osteoporosis monographs (2026), Aether Forge

## Follow-up

- Three-month review in nine weeks. Stop chlorthalidone and call if she cannot eat or drink normally. **S**
- Next scheduled visit 1877-06-15: three-month review after chlorthalidone was stopped: blood pressure above target, losartan added; lipids on atorvastatin; knee and falls. **S**
